Business Description
Faron Pharmaceuticals, founded in 2003 and based in Turku, Finland, is a clinical-stage biotech company focused on developing new treatments for cancer and serious immune-related conditions. Its most advanced drug, bexmarilimab, works by reprogramming certain immune cells within tumors to help the body fight cancer more effectively, and is being tested across a range of blood cancers and solid tumors. The company is also exploring how key immune receptors influence organ damage and bone marrow recovery.
